Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

News All News

CBS 2023: Abstract Submission Open 0 comments

by Amanda Clifford
Dear Members, Abstract submission is open for CBS 2023 at Dalhousie University in Halifax, NS. Please submit your abstract on the conference website www...
more

WBC 2024 Symposia Proposal Submission Deadline Extended 0 comments

by Amanda Clifford
Dear Members, The symposia proposal submission deadline for WBC 2024 has been extended to January 30, 2023...
more

Call for Papers: Exploration of Biomat-X 0 comments

by Amanda Clifford
The Editorial Board of Exploration of Biomat-X EBMX is excited to invite Canadian Biomaterials Society members to submit your next original contribution to the inaugural edition of this journal...
more

Membership Fee Increase 0 comments

by Amanda Clifford
Please note that the CBS Board of Directors has approved an increase in membership fees, effective immediately...
more

Meetings All Meetings

Discover

Title: Novel Grooved Substrata Stimulate Macrophage Fusion, CCL2 and MMP-9 Secretion comments

by Haisle Moon
The monocyte-derived macrophage is one of the first cell types found on newly implanted devices and is known to play a role in inflammation, immunoregulation and wound healing depending on its functional phenotype...
more

Development of a Superior Decellularized Human Dermal Product for Advanced Wound Care: From Basic Science to Clinical Application comments

by Paul Gratzer
The decellularization of tissues has evolved as a natural extension of using allogeneic and xenogeneic grafts to replace parts of the body...
more

Nano-spray therapy for treating heart attacks comments

by Emilio Alarcon Marcelo Munoz
We present a nano-spray therapy for on-the spot-repair of a heart attack. Our sprayable therapy uses nano-engineered peptide-based materials, where nanomolar concentrations of surface engineered spherical nanogold are used to coat the surface of the cardiac muscle...
more

Chitosan Thermogels for Local T Lymphocyte Delivery in Cancer Immunotherapy comments

by Caroline Ceccaldi
Systemic adoptive T lymphocyte transfer is an emerging cancer immunotherapy showing tremendous promise in clinical studies, and its success lies in the ability of the antigen-experienced cytotoxic T lymphocytes cTL to access and to persist in the tumour microenvironment 1 ...
more

Development of encapsulated cell product to treat ischemic diseases comments

by Francesco Touani Kameni
Mesenchymal stromal cell MSC therapy is a promising treatment to stimulate vascular regeneration in ischemic tissues...
more

Connect

Active Job Postings

  • TIER 2 CANADA RESEARCH CHAIR IN CELL ENGINEERING AND BIOMANUFACTURING
    more
  • Assistant, Associate, or Full Professor in Bioprocessing and Biomanufacturing
    more
  • Research Associate in Next-Generation RNA Therapeutics at UBC
    more
  • Research Associate in Next-Generation RNA Therapeutics at UBC
    more

Recent Member Projects

  • Doris Liang: Mineralization in fractured femurs
    more
  • Dena Shahriari: Assistant Professor
    more
  • Samuel Tretjakov: Samuel Tretjakov
    more
  • Marie Billaud: Double encapulsation device for type 1 diabetes
    more

Recent Member Publications

  • Robyn Birch: Denosumab treatment of giant cell tumors in the spine induces woven bone formation
    more
  • Daniel Nguyen: Mechanically Stable and Tunable Photoactivated Peptide-Based Hydrogels for Soft Tissue Adhesion
    more
  • German Andres Mercado: Mechanically Stable and Tunable Photoactivated Peptide-Based Hydrogels for Soft Tissue Adhesion
    more
  • German Andres Mercado: Multipurpose On-the-Spot Peptide-Based Hydrogels for Skin, Cornea and Heart Repair
    more
Close Drag